Status | Study |
Withdrawn |
Study Name: Characterization of the Profile of Dysarthria in Huntington's Disease, Using the Clinical Evaluation Battery of Dysarthria Condition: Dysarthria Huntington Disease Date: 2017-05-03 Interventions: Other: Study of dysarthria in patients with Huntington's disease Study of dysarthria in patients with Hu |
Recruiting |
Study Name: Beta Testing of a New Assessment in Huntington's Disease (HD) Condition: Huntington Disease Date: 2016-08-25 Interventions: Other: CAPIT-HD beta New assessment protocol for assessment of complex therapies in Huntington's disease |
Recruiting |
Study Name: Deep Brain Stimulation (DBS) of the Globus Pallidus (GP) in Huntington's Disease (HD) Condition: Huntington Disease Date: 2015-08-27 Interventions: Device: ACTIVA® PC neurostimulator (Model 37601) the stimulator in the stimulation group will be tu |
Terminated |
Study Name: Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021 Condition: Huntington's Disease Date: 2015-01-15 Interventions: Drug: 20 mg BID of PF-02545920 All subject who completed A8241021 will receive 20 mg BID (with or withou |
Completed |
Study Name: Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease Condition: Huntington's Disease Date: 2014-07-16 Interventions: Drug: PF-02545920 20 mg twice |
Active, not recruiting |
Study Name: Alternatives for Reducing Chorea in HD Condition: Chorea Associated With Huntington Disease Date: 2013-06-14 Interventions: Drug: SD-809 SD-809 tablets will be provided in dose strengths of 6, 9 and 12 mg. |
Completed |
Study Name: Safety and Efficacy of Bone Marrow Derived MNCs for Treatment of Cells for the Treatment of Hunting Tons Chorea. Condition: Huntington Disease Date: 2013-04-11 Interventions: Biological: autologous Stem Cell Intrathecal transplantation of autologous 100 millions Stem cells{MNCs |
Completed |
Study Name: First Time Use of SD-809 in Huntington Disease Condition: Chorea Date: 2013-02-20 Interventions: Drug: SD-809 SD-809 tablets ar |
Completed |
Study Name: A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington Disease Condition: Huntington's Disease Date: 2011-11-29 Interventions: Drug: SEN0014196 100 mg, immediate release tablets, once daily administration |
Completed |
Study Name: An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196 Condition: Huntington Disease Date: 2011-11-29 Interventions: Drug: SEN0014196 (Low Dose) 10 |